Details
Original language | English |
---|---|
Pages (from-to) | 37-49 |
Number of pages | 13 |
Journal | EMBO molecular medicine |
Volume | 1 |
Issue number | 1 |
Publication status | Published - 26 Mar 2009 |
Externally published | Yes |
Abstract
A novel class of antibiotic acyldepsipeptides (designated ADEPs) exerts its unique antibacterial activity by targeting the peptidase caseinolytic protease P (ClpP). ClpP forms proteolytic complexes with heat shock proteins (Hsp100) that select and process substrate proteins for ClpP-mediated degradation. Here, we analyse the molecular mechanism of ADEP action and demonstrate that ADEPs abrogate ClpP interaction with cooperating Hspi00 adenosine triphosphatases (ATPases). Consequently, ADEP treated bacteria are affected in ClpP-dependent general and regulatory proteolysis. At the same time, ADEPs also activate ClpP by converting it from a tightly regulated peptidase, which can only degrade short peptides, into a proteolytic machinery that recognizes and degrades unfolded polypeptides. In vivo nascent polypeptide chains represent the putative primary target of ADEP-activated ClpP, providing a rationale for the antibacterial activity of the ADEPs. Thus, ADEPs cause a complete functional reprogramming of the Clp-protease complex.
Keywords
- ADEP, Antibiotic, Clp proteins, ClpP, Hsp100, Proteolysis
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
- Molecular Medicine
Cite this
- Standard
- Harvard
- Apa
- Vancouver
- BibTeX
- RIS
In: EMBO molecular medicine, Vol. 1, No. 1, 26.03.2009, p. 37-49.
Research output: Contribution to journal › Article › Research › peer review
}
TY - JOUR
T1 - The antibiotic ADEP reprogrammes CIpP, switching it from a regulated to an uncontrolled protease
AU - Kirstein, Janine
AU - Hoffmann, Anja
AU - Lilie, Hauke
AU - Schmidt, Ronny
AU - Helga, Rubsamen Waigmann
AU - Heike, Brötz Oesterhelt
AU - Mogk, Axel
AU - Turgay, Kürşad
N1 - Copyright: Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2009/3/26
Y1 - 2009/3/26
N2 - A novel class of antibiotic acyldepsipeptides (designated ADEPs) exerts its unique antibacterial activity by targeting the peptidase caseinolytic protease P (ClpP). ClpP forms proteolytic complexes with heat shock proteins (Hsp100) that select and process substrate proteins for ClpP-mediated degradation. Here, we analyse the molecular mechanism of ADEP action and demonstrate that ADEPs abrogate ClpP interaction with cooperating Hspi00 adenosine triphosphatases (ATPases). Consequently, ADEP treated bacteria are affected in ClpP-dependent general and regulatory proteolysis. At the same time, ADEPs also activate ClpP by converting it from a tightly regulated peptidase, which can only degrade short peptides, into a proteolytic machinery that recognizes and degrades unfolded polypeptides. In vivo nascent polypeptide chains represent the putative primary target of ADEP-activated ClpP, providing a rationale for the antibacterial activity of the ADEPs. Thus, ADEPs cause a complete functional reprogramming of the Clp-protease complex.
AB - A novel class of antibiotic acyldepsipeptides (designated ADEPs) exerts its unique antibacterial activity by targeting the peptidase caseinolytic protease P (ClpP). ClpP forms proteolytic complexes with heat shock proteins (Hsp100) that select and process substrate proteins for ClpP-mediated degradation. Here, we analyse the molecular mechanism of ADEP action and demonstrate that ADEPs abrogate ClpP interaction with cooperating Hspi00 adenosine triphosphatases (ATPases). Consequently, ADEP treated bacteria are affected in ClpP-dependent general and regulatory proteolysis. At the same time, ADEPs also activate ClpP by converting it from a tightly regulated peptidase, which can only degrade short peptides, into a proteolytic machinery that recognizes and degrades unfolded polypeptides. In vivo nascent polypeptide chains represent the putative primary target of ADEP-activated ClpP, providing a rationale for the antibacterial activity of the ADEPs. Thus, ADEPs cause a complete functional reprogramming of the Clp-protease complex.
KW - ADEP
KW - Antibiotic
KW - Clp proteins
KW - ClpP
KW - Hsp100
KW - Proteolysis
UR - http://www.scopus.com/inward/record.url?scp=71749110235&partnerID=8YFLogxK
U2 - 10.1002/emmm.200900002
DO - 10.1002/emmm.200900002
M3 - Article
AN - SCOPUS:71749110235
VL - 1
SP - 37
EP - 49
JO - EMBO molecular medicine
JF - EMBO molecular medicine
SN - 1757-4676
IS - 1
ER -